Committee for Orphan Medicinal Products
Committee for Orphan Medicinal Products
 |
| Dr. Kerstin Westermark, COMP Chair |
The Committee for Orphan Medicinal Products (COMP), headquartered in London, was created in 2000 within the European Medicines Agency (EMA) and is responsible for reviewing applications from people or companies seeking 'orphan medicinal product designation'.
Activities and role
The COMP is also responsible for advising the European Commission on the establishment and development of a policy on orphan medicinal products in the EU, and assists the Commission in drawing up detailed guidelines and liaising internationally on matters relating to orphan medicinal products.The COMP is composed of:
- a chairperson, elected by serving COMP members;
- one member nominated by each of the 27 EU Member States;
- three members nominated by the European Commission to represent patients'
organisations; - three members nominated by the European Commission on the EMA's recommendation;
- one member nominated by each of the EEA-EFTA states (Iceland, Liechtenstein
and Norway); - one European Commission representative;
- general observers.
EURORDIS representation at COMP:
In addition to voting members, a number of Observers attend COMP meetings,
including two EURORDIS representatives.
 |  |
| Mrs. Birthe Byskov Holm, Vice-chair of COMP EURORDIS nominated Patient Representative Current mandate: July 2009 – 2012 Danish Osteogenesis Imperfecta Association | Mrs. Lesley Greene EURORDIS nominated Patient Representative Current mandate: July 2009 – 2012 Vice-president of CLIMB |
 | |
| Dr. Maria Mavris, EURORDIS Observer | |
For further information:
Committee for Orphan Medicinal Products (COMP)Scientific Advice and Orphan Drugs
Pre-authorisation
Evaluation of Medicines for Human Use
7 Westferry Circus
Canary Wharf
London E14 4 HB
United Kingdom
Tel: + (44-20) 74 18 84 00
Fax: + (44-20) 75 23 70 40
e-mail: info@ema.europa.eu
More information at http://www.ema.europa.eu/htms/general/contacts/COMP/COMP.html.
Photos & graphics: © EMA
.png)
No hay comentarios:
Publicar un comentario